🔗 Share this article

Chancellor Reeves has stated she is planning "specific steps to tackle household expense issues" in next month's Budget.

In comments to the BBC, she emphasized that curbing inflation is a collective task of both the government and the central bank.

The United Kingdom's price growth is expected to be the most elevated among the G7 developed nations this year and next.

Possible Utility Cost Measures

It is understood the administration could take action to lower utility costs, such as by slashing the current 5% rate of VAT applied on energy.

An additional possibility is to lower some of the government charges presently included in bills.

Budgetary Limitations and Expert Expectations

The administration will obtain the latest assessment from the official forecaster, the Office for Budget Responsibility, on the start of the week, which will clarify how much room there is for such actions.

The consensus from most economists is that Reeves will have to announce higher taxes or expenditure reductions in order to fulfill her self-imposed fiscal targets.

Previously on the same day, analysis indicated there was a £22 billion shortfall for the chancellor to resolve, which is at the more modest range of expectations.

"There's a joint responsibility between the central bank and the government to continue tackling some of the causes of price increases," the Chancellor told reporters in the US capital, at the annual meetings of the IMF and global financial institution.

Tax Commitments and International Concerns

While a great deal of the focus has been on likely tax rises, the Treasury chief said the latest figures from the OBR had not altered her pledge to manifesto promises not to raise tax levels on income tax, sales tax or National Insurance.

She blamed an "unpredictable world" with growing geopolitical and trade tensions for the fiscal tax moves, likely to be focused on those "with the broadest shoulders."

Global Economic Disputes

Addressing apprehensions about the UK's trade ties with China she said: "Our national security invariably are paramount."

Last week's statement by Chinese authorities to tighten trade restrictions on critical minerals and other materials that are essential for high-technology manufacturing led American leader Donald Trump to propose an further 100% import tax on imports from the Asian country, increasing the prospect of an full-scale commercial conflict between the two largest economies.

The US Treasury Secretary described the Chinese decision "economic coercion" and "a global supply chain power grab."

Inquired about accepting the US offer to join its conflict with the Asian nation, the Chancellor said she was "deeply worried" by China's actions and called on the Beijing authorities "to avoid restrictions and limit trade."

She said the move was "bad for the world economy and generates further challenges."

"I believe there are areas where we must confront Chinese policies, but there are also significant opportunities to export to Chinese markets, including banking sector and other areas of the economic system. We've got to achieve that balance correct."

The Treasury chief also affirmed she was collaborating with other major economies "on our own essential resources plan, so that we are less reliant."

Health Service Drug Pricing and Investment

The Chancellor also acknowledged that the cost the National Health Service pays for medicines could increase as a consequence of current negotiations with the Trump administration and its pharmaceutical firms, in exchange for lower tariffs and funding.

Some of the biggest global drug companies have said in recent statements that they are either pausing or abandoning investments in the United Kingdom, with some blaming the insufficient payments they are obtaining.

Recently, the government science advisor said the price the health service pays for drugs would must rise to halt firms and drug research funding leaving the UK.

Reeves told media: "We have seen due to the pricing regime, that medical research, innovative medicines have not been offered in the United Kingdom in the manner that they are in other continental states."

"Our aim is to guarantee that patients getting care from the National Health Service are can access the top critical drugs in the globe. And so we are reviewing all of that, and... seeking to secure more funding into the UK."